Lenalidomide Could Improve Survival, Reduce Progression in 5q-Deletion MDS
Targeted Oncology – Sept. 8
Lenalidomide (Revlimid) has provided evidence of potential to improve survival and reduce the leukemic progression in patients with 5q-deletion (del[5q]) myelodysplastic syndrome (MDS), according to a review of the evidence by Alan List, MD, CEO of Moffitt Cancer Center, during a keynote address at the 2016 Society of Hematologic Oncology annual meeting.
Exploring Lenalidomide Potential for Cure in 5q-Deletion MDS
OncLive – Sept. 8
“Treatment with lenalidomide in 5q-deletion MDS yields high rates of transfusion independence and cytogenetic response,” Alan List, MD, CEO of Moffitt Cancer Center, said during a keynote address at the 2016 Society of Hematologic Oncology annual meeting.
Dr. Strosberg on the Results of the NETTER-1 Trial
OncLive – Sept. 7
Jonathan Strosberg, MD, associate professor, Moffitt Cancer Center, discusses the results of the NETTER-1 trial.
Advances for Multiple Myeloma Patients
WTLV – Sept. 7
Dr. Kenneth Shain with Moffitt Cancer Center is joining us now to discuss some of the advances for multiple myeloma patients.
Moffitt leader’s MD-CEO combo earns national recognition
Tampa Bay Business Journal – Sept. 7
Dr. Alan List, president and CEO of Moffitt Cancer Center, is the only leader from Tampa Bay named to Becker’s Hospital Review’s 110 Physician Leaders of Hospitals and Health Systems list.
Those curious changes in your kid’s skin
Lifezette – Sept. 7
The sun is not always your friend,” said Dr. Vernon K. Sondak, chair of the department of cutaneous oncology at Moffitt Cancer Center and Research Institute in Tampa, Florida. “Protect the skin you’re in — it’s the only one you’re going to get.
Officer, father and friend fights cancer
Coastal Breeze News – Sept. 6
He has already undergone two surgeries, and a third is scheduled for late October at the Moffitt Cancer Center in Tampa. The procedure involves removing the cancer and reconstructive surgery to rebuild his nasal cavity and palate.
110 Physician Leaders to Know 2016
Becker’s Hospital Review – Sept. 6
Alan List, MD. President and CEO of Moffitt Cancer Center (Tampa, Fla.). In addition to serving as president and CEO of Moffitt Cancer Center, Dr. List is internationally recognized for his contributions to the development of more effective treatment strategies for myelodysplastic syndrome and acute myeloid leukemia.
Networking with Dr. God
Science Magazine – Sept. 6
In 2009, Eric Padron—at the time in the first year of his fellowship at Moffitt Cancer Center in Tampa, Florida—was looking for a role model with whom he could develop a research alliance. “I thought, ‘Who’s a person who’s extremely well respected in their field [and] has a reputation of being nice and productive to work with?’” he says. “At the top of the list, no pun intended, was Dr. List,” referring to Alan List, an internationally renowned expert in malignant hematology who later became Moffitt’s president and CEO.
Moffitt Cancer Center Liver Team is First to Perform Special Modified Liver Surgery
Tampa Patch – Sept. 6
Her physician at Moffitt Cancer Center recommended chemotherapy and said she would bring up Rio’s case in the liver tumor board meeting to see if any other physicians could offer any additional treatments.
Orchestra Hits The Road For Community Concerts
WUSF – Sept. 5
Orchestra members also will be performing during this time at St. Joseph’s-North Hospital in Lutz (Sept. 22), Tampa General Hospital (Sept. 23), Moffitt Cancer Center (Sept. 23), and on Sept. 21-22 at veterans’ and retirement centers, and the Pinellas Park Boys and Girls Club.
Dr. Levine on Evolving Treatment Options for Patients With mCRPC
OncLive – Sept. 5
Richard M. Levine, MD, medical director, Moffitt International Plaza, Moffitt Cancer Center, discusses the available agents and their benefits for patients with metastatic castration-resistant prostate cancer (mCRPC).
Florida Orchestra presents free concerts in September, beyond
Tampa Bay Times – Sept. 2
During "TFO on the Go," Francis will lead the orchestra in performances for patients and staff of St. Joseph's-North Hospital, the Moffitt Cancer Center and Tampa General Hospital. Smaller chamber groups will appear at places like the Pinellas Park Boys and Girls Club, retirement homes and veterans centers.
Dr. Johnstone on Immediate Salvage Therapy for Prostate Cancer
OncLive – Sept. 2
Peter A. Johnstone, MD, vice chair, Department of Radiation Oncology, Moffitt Cancer Center, discusses immediate salvage therapy for patients with prostate cancer and the most common physician questions surrounding the treatment.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.